Phase I trial of an embryonic stem cell-based treatment for amyotrophic lateral sclerosis.

Trial Profile

Phase I trial of an embryonic stem cell-based treatment for amyotrophic lateral sclerosis.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 21 Jun 2017

At a glance

  • Drugs Stem cell therapies (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Adverse reactions
  • Sponsors Kadimastem
  • Most Recent Events

    • 21 Jun 2017 According to a Kadimastem media release, company recieved approval from the IRB (Helsinki Committee) of the Hadassah Ein Kerem Hospital for this study.
    • 15 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top